DSHEA at 25

Dr Rob Wildman on NDI submissions, implementing MPL

Dr Rob Wildman on NDI submissions, implementing MPL

By Danielle Masterson

This year’s International Society of Sports Nutrition Annual Conference & Expo marked its 19th year promoting the science and application of evidence-based sports nutrition and supplementation. NutraIngredients-USA was there to hear about the latest...

©Getty Images - Klaus Vedfelt

Guest article

Industry needs consensus in 2022, CRN says

By Steve Mister, President and CEO, Council for Responsible Nutrition

As the dietary supplement industry turns the corner to 2022, a range of challenges confronts us— supply chain disruptions, staffing shortages, and inflationary pressures, to name a few. Some difficulties must be addressed individually, but I suggest the...

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

AHPA's McGuffin on DSHEA 2.0, CBD's path forward, and more

By Stephen Daniells

While AHPA supports H.R.841, the association wishes FDA “would do its job and establish a legal pathway [for hemp and CBD], but they haven’t,” said Michael McGuffin. “Something needs to happen.”

©Getty Images - ptasha

NutraIngredients-USA Awards 2020

CRN's Label Wise effort stood out among year's industry initiatives

By Hank Schultz

Making nutrition understandable for everyone is the goal of the Label Wise initiative led by the Council for Responsible Nutrition. That made it a clear choice for this year’s Editors Award for Industry Initiative of the Year.

Getty Images / DIPA

Notes from CRN/ACI Annual Legal, Regulatory and Compliance Forum on Dietary Supplements

The case for mandatory product listing, and the arguments against it

By Adi Menayang

Controversy swirls around whether dietary supplement brands should be required to register the products they have on the market with FDA. Two attorneys debated the risks and benefits of a mandatory product registry yesterday at the CRN/ACI Annual Legal,...

Turmeric has thousands of studies behind it.  But many have been done to disease end points.  Getty Images

From the Editor's Desk

Can DSHEA 2.0 fix the 'education' question?

By Hank Schultz

Advocates are unanimous in saying that natural products could always benefit from more research. But what about when that research looks at disease endpoints?

Getty Images

DSHEA at 25

Balancing consumer access and safety

By Michael McGuffin, president, American Herbal Products Association

Looking back 25 years, there are several remarkable aspects of the Dietary Supplement Health and Education Act (DSHEA) amendments to the Food Drug and Cosmetic Act (FD&C Act), which transformed how dietary supplements are regulated.

DSHEA at 25: In conversation with Scott Bass and Loren Israelsen

WATCH THE FULL INTERVIEW

DSHEA at 25: In conversation with Scott Bass and Loren Israelsen

By Stephen Daniells

The brilliant strategy of Sen. Orrin Hatch, the upswell of grassroots consumer pressure, and the ‘highly unusual’ personal intervention of an FDA Commissioner: The development and passage of the Dietary Supplement Health and Education Act is a fascinating...

Getty Images

From the editor's desk

What should DSHEA 2.0 look like? Here are a couple of suggestions

By Hank Schultz

On Monday FDA Commissioner Scott Gottlieb put forward some ideas about where the regulation of dietary supplements should go in the coming years. This is an opportunity that should not be missed. What should be tops on the industry’s wish list?

Getty Images

The big issues for 2019: CBD, the microbiome and more

By Stephen Daniells, Hank Schultz and Adi Menayang

The year is new and many people are getting out their crystal balls. NutraIngredients-USA is no different, and here are five of our Top 10 big issues that will impact the dietary supplements industry in 2019.

Follow us

Products

View more

Webinars